Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
5.45
-0.01 (-0.18%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Quoin Pharmaceuticals Market Cap
Quoin Pharmaceuticals has a market cap or net worth of $9.83 million as of April 29, 2026. Its market cap has increased by 204.42% in one year.
Market Cap
9.83M
Enterprise Value
-6.59M
1-Year Change
204.42%
Ranking
Category
Stock Price
$5.45
Market Cap Chart
Since October 29, 2021, Quoin Pharmaceuticals's market cap has decreased from $97.17M to $9.83M, a decrease of -89.88%. That is a compound annual growth rate of -39.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 9.83M | -18.81% |
| Dec 31, 2025 | 12.11M | 127.24% |
| Dec 31, 2024 | 5.33M | 10.02% |
| Dec 29, 2023 | 4.84M | -29.65% |
| Dec 30, 2022 | 6.88M | -54.69% |
| Dec 31, 2021 | 15.19M | -84.36% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Imunon | 10.79M |
| CytoMed Therapeutics | 10.65M |
| Chemomab Therapeutics | 10.62M |
| Enveric Biosciences | 10.56M |
| BioLineRx | 10.52M |
| Kiora Pharmaceuticals | 10.23M |
| Aprea Therapeutics | 9.58M |
| Bolt Biotherapeutics | 9.30M |